The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Washington – A group of labor unions are asking a federal court for an emergency order to stop Elon Musk 's Department of Government Efficiency from accessing the sensitive Social Security data ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

Bloomberg reports the obesity drug market is expected to reach as much as $130 billion in annual sales by 2030.

Humira, AbbVie’s mega blockbuster ... Spain, UK, Japan, and China). Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

This will give you more editing options and generally results in higher-quality photos, which you can send without compression using the HD photo quality option. You can also send pictures or ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.